Differential Inverse Agonism at the Human Muscarinic M3 Receptor

作者: Paola Casarosa , Tobias Kiechle , Remko A. Bakker

DOI: 10.1016/B978-0-12-381296-4.00005-1

关键词:

摘要: Human muscarinic M3 receptors (hM3Rs) induce smooth muscle contraction and mucus gland secretion in response to parasympathetic stimulation. As a consequence of hM3R function, antagonists have wide therapeutic use treat overactive bladder, abdominal pain (irritable bowel syndrome), chronic obstructive pulmonary disease (COPD). In this chapter, we describe the set up results obtained with different vitro assays monitor activation (agonist-dependent constitutive) evaluate functional potencies anticholinergics CHO cells. Given Gq coupling hM3R, measuring second messengers inositol phosphates (InsP) an AP-1-driven reporter luciferase were developed. In our hands, gene assay shows advantages: firstly, thanks longer incubation times, it allows reaching pseudo-equilibrium also for ligands slower receptor dissociation kinetics (e.g., tiotropium). Secondly, detects significant constitutive activity which characterizing their inverse agonist properties. potential agonists cause changes expression, monitoring upregulation is another important pharmacological parameter. Here, how measure effect exposure on expression levels particular attention ensure full antagonist removal from pool before quantification. Taken together, indicate that exhibit differential behaviors, are dependent pathway investigated, therefore provide evidence molecular mechanism agonism likely be more complex than stabilization single inactive conformation.

参考文章(32)
R P Yasuda, B B Wolfe, W Ciesla, M Li, S J Wall, Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration Journal of Pharmacology and Experimental Therapeutics. ,vol. 262, pp. 584- 588 ,(1992)
G. Milligan, R.A. Bond, Inverse agonism and the regulation of receptor number Trends in Pharmacological Sciences. ,vol. 18, pp. 468- 474 ,(1997) , 10.1016/S0165-6147(97)01139-5
Peter J. Barnes, The role of anticholinergics in chronic obstructive pulmonary disease. The American Journal of Medicine. ,vol. 117, pp. 24- 32 ,(2004) , 10.1016/J.AMJMED.2004.10.018
Eric N. Johnson, Kirk M. Druey, Heterotrimeric G protein signaling: role in asthma and allergic inflammation. The Journal of Allergy and Clinical Immunology. ,vol. 109, pp. 592- 602 ,(2002) , 10.1067/MAI.2002.122636
Jürgen Wess, Richard M. Eglen, Dinesh Gautam, Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nature Reviews Drug Discovery. ,vol. 6, pp. 721- 733 ,(2007) , 10.1038/NRD2379
B. Chevalier, P. Mansier, E. Teiger, F. Callens-El Amrani, B. Swynghedauw, Alterations in β adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine Mechanisms of Ageing and Development. ,vol. 60, pp. 215- 224 ,(1991) , 10.1016/0047-6374(91)90132-J
Nirish Shah, Sandeep Khurana, Kunrong Cheng, Jean-Pierre Raufman, Muscarinic receptors and ligands in cancer American Journal of Physiology-cell Physiology. ,vol. 296, ,(2009) , 10.1152/AJPCELL.00514.2008
Ilaria Peretto, Paola Petrillo, Bruno P. Imbimbo, Medicinal Chemistry and Therapeutic Potential of Muscarinic M3 Antagonists Medicinal Research Reviews. ,vol. 29, pp. 867- 902 ,(2009) , 10.1002/MED.20158
Ethan S. Burstein, Tracy A. Spalding, Hans Braüner-Osborne, Mark R. Brann, Constitutive activation of muscarinic receptors by the G-protein Gq FEBS Letters. ,vol. 363, pp. 261- 263 ,(1995) , 10.1016/0014-5793(95)00323-2
Terry Kenakin, Ligand-selective receptor conformations revisited: the promise and the problem Trends in Pharmacological Sciences. ,vol. 24, pp. 346- 354 ,(2003) , 10.1016/S0165-6147(03)00167-6